Literature DB >> 16103736

Correlation between laminin-5 gamma2 chain and epidermal growth factor receptor expression in esophageal squamous cell carcinomas.

Yasuyuki Fukai1, Norihiro Masuda, Hiroyuki Kato, Minoru Fukuchi, Tatsuya Miyazaki, Masanobu Nakajima, Makoto Sohda, Hiroyuki Kuwano, Takashi Nakajima.   

Abstract

OBJECTIVES: Laminin-5 gamma2 chain (LN-5 gamma2) is an extracellular matrix protein that plays an important role in cell migration and tumor invasion. We evaluated the association of LN-5 gamma2 and epidermal growth factor receptor (EGFR) expression in esophageal squamous cell carcinoma (SCC).
METHODS: LN-5 gamma2 and EGFR expression was evaluated in 110 esophageal SCC patients by immunohistochemistry, and was confirmed using esophageal SCC cell lines by Western blot analysis.
RESULTS: LN-5 gamma2 expression in the invasive front of the tumor was correlated with the depth of invasion (p = 0.0001), lymph node metastasis (p = 0.0011) and pathological stage (p = 0.0001). The strong expression of EGFR was also correlated with lymph node metastasis (p = 0.0456) and the pathological stage (p = 0.0055). In patient survival, LN-5 gamma2 positivity and/or strong EGFR expression showed a significantly low survival rate as compared with those with lesser expression of LN-5 gamma2 and EGFR. Immunohistochemically, LN-5 gamma2 expression was significantly correlated with EGFR expression (p < 0.0001). Western blot analysis also confirmed the correlated expression of LN-5 gamma2 and EGFR in SCC cell lines except 2 of the 5 cell lines.
CONCLUSIONS: This study suggests that coexpression of LN-5 gamma2 and EGFR is closely related to the progression and poor prognosis of esophageal SCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103736     DOI: 10.1159/000087477

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  16 in total

1.  C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome.

Authors:  Ya-Ping Xu; Gang Lin; Xiao-Jiang Sun; Mao-Hui Yan; Gu Zhang; Jin-Lin Hu; Wen-Yong Sun; Jin-Ming Yu
Journal:  J Cancer       Date:  2016-03-18       Impact factor: 4.207

Review 2.  Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.

Authors:  Li Shang; Mingrong Wang
Journal:  Front Med       Date:  2013-09-03       Impact factor: 4.592

3.  Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy.

Authors:  She-Juan An; Yi-Sheng Huang; Zhi-Hong Chen; Jian Su; Yan Yang; Jian-Guang Chen; Hong-Hong Yan; Qiu-Xiong Lin; Jin-Ji Yang; Xue-Ning Yang; Qing Zhou; Xu-Chao Zhang; Yi-Long Wu
Journal:  Med Oncol       Date:  2011-04-03       Impact factor: 3.064

4.  Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.

Authors:  Kazuhiro Sentani; Miho Matsuda; Naohide Oue; Naohiro Uraoka; Yutaka Naito; Naoya Sakamoto; Wataru Yasui
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

5.  A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancer.

Authors:  Cherise M Guess; Bonnie J Lafleur; Brandy L Weidow; Vito Quaranta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

Review 6.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

7.  Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China.

Authors:  Jian-Zhong Shou; Nan Hu; Mikiko Takikita; Mark J Roth; Laura Lee Johnson; Carol Giffen; Quan-Hong Wang; Chaoyu Wang; Yuan Wang; Hua Su; Li-Hui Kong; Michael R Emmert-Buck; Alisa M Goldstein; Stephen M Hewitt; Philip R Taylor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

8.  Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer.

Authors:  She-Juan An; Qiu-Xiong Lin; Zhi-Hong Chen; Jian Su; Hua Cheng; Zhi Xie; Xu-Chao Zhang; Hai-Yu Zhou; Ying Huang; Shi-Liang Chen; Wei-Bang Guo; Yi-Long Wu
Journal:  Exp Ther Med       Date:  2012-05-16       Impact factor: 2.447

9.  E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.

Authors:  K Araki; T Shimura; H Suzuki; S Tsutsumi; W Wada; T Yajima; T Kobayahi; N Kubo; H Kuwano
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

10.  Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation.

Authors:  Y Baba; K-I Iyama; K Hirashima; Y Nagai; N Yoshida; N Hayashi; N Miyanari; H Baba
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.